feedburner

Enter your email address:

Delivered by FeedBurner

Bharat Biotech to start Phase-1 trials of COVID-19 intranasal vaccine in Feb-March

Besides Covaxin, BharatBiotech has been actively working on developing
another vaccine, for which it tied up with Washington UniversitySchool
of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee
adenovirus), a single dose intranasal vaccine for COVID-19.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-start-phase-1-trials-of-covid-19-intranasal-vaccine-in-feb-march/articleshow/80166140.cms



0 comments:

Post a Comment